Assessing the bone height changes around the dental implants with the use of rh-BMP-2 as a coating around implants.
Phase 4
- Conditions
- Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
- Registration Number
- CTRI/2024/05/067147
- Lead Sponsor
- Moturi Padmini Raj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Individuals with an age group of 25-50 years of either gender.
2.Presence of adequate horizontal(4-5mm) and vertical (12mm) dimensions of the alveolar bone based on CBCT.
3.Presence of adequate keratinized mucosa (minimum 1 mm) in the edentulous site.
4.Apparently healthy individuals.
5.Individuals with bone density classified as D2 and D3 type of bone.
Exclusion Criteria
1.Any forms of tobacco users.
2.Pregnant and lactating women.
3.Subjects taking any medication which effect healing and bone metabolism.
4.Individuals with parafunctional habits.
5.History of radiotherapy to head and neck.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the implant stability around implants coated with rhBMP-2 gel.Timepoint: Baseline and 3 months
- Secondary Outcome Measures
Name Time Method To evaluate the crestal bone level around implants coated with rhBMP-2 gel.Timepoint: Baseline ,3 months and 6 months